Patents by Inventor Ruth Milz

Ruth Milz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosing regimens associated with extended release paliperidone injectable formulations
    Patent number: 12053474
    Abstract: The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: August 6, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ruth Milz, Frank Wiegand, Panna Sanga, John Louie
  • Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
    Publication number: 20230077039
    Abstract: The present invention provides methods of treating patients with long acting injectable paliperidone palmitate formulations. The disclosure includes methods for mitigating at least one adverse change in blood lipid levels of a patient in need thereof who has been treated with a paliperidone palmitate extended-release injectable suspension at either one-month intervals (PP1M) or three-month intervals (PP3M), comprising transitioning the patient to a paliperidone palmitate extended-release injectable suspension having a six month dosing interval (PP6M).
    Type: Application
    Filed: August 15, 2022
    Publication date: March 9, 2023
    Inventors: Srihari Gopal, Ruth Milz, Steven Wang, Dean Najarian, Panna Sanga, John Louie
  • Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
    Publication number: 20230010558
    Abstract: The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 12, 2023
    Inventors: Ruth Milz, Frank Wiegand, Panna Sanga, John Louie
  • Dosing regimens associated with extended release paliperidone injectable formulations
    Patent number: 11439647
    Abstract: The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: September 13, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ruth Milz, Frank Wiegand, Panna Sanga, John Louie
  • Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
    Publication number: 20220168305
    Abstract: The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
    Type: Application
    Filed: May 7, 2021
    Publication date: June 2, 2022
    Inventors: Ruth Milz, Frank Wiegand, Panna Sanga, John Louie